CryoPort, Inc. (CYRX)
| Market Cap | 1.23B |
| Revenue (ttm) | 221.63M |
| Net Income (ttm) | -293.41M |
| Shares Out | 49.38M |
| EPS (ttm) | -6.19 |
| PE Ratio | n/a |
| Forward PE | 131.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 84,668 |
| Open | 23.33 |
| Previous Close | 23.09 |
| Day's Range | 23.33 - 24.94 |
| 52-Week Range | 19.82 - 86.30 |
| Beta | 1.28 |
| Analysts | Buy |
| Price Target | 54.29 (+117.7%) |
| Earnings Date | May 5, 2022 |
About CYRX
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the...
Financial Performance
In 2021, CryoPort's revenue was $222.61 million, an increase of 182.87% compared to the previous year's $78.70 million. Losses were -$275.53 million, 742.8% more than in 2020.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for CYRX stock is "Buy." The 12-month stock price forecast is 54.29, which is an increase of 117.68% from the latest price.
News
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -55% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Cryoport Reports First Quarter 2022 Results
Revenue of $52.3 million Provides Full Year 2022 Revenue Guidance of $260-$265 million Expansion and advancement of robust clinical pipeline continues – now supporting a record 609 clinical trials, with...
Cryoport to Report First Quarter 2022 Financial Results on May 5, 2022
NASHVILLE, Tenn. , April 28, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu...
Cryoport Acquires Cell&Co BioServices
Acquisition of Cell&Co BioServices, Clermont-Ferrand, France, accelerates Company's EMEA expansion plans and development of its Global Supply Chain Network NASHVILLE, Tenn. , April 18, 2022 /PRNewswire/...
Cryoport's MVE Biological Solutions' New Prague Manufacturing Plant Returns to Full Production
Company provides further update on financial impact of New Prague, MN fire NASHVILLE, Tenn., March 30, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader i...
Cryoport Authorizes $100 Million Repurchase Program
Management Presenting at Upcoming Investor Conferences NASHVILLE, Tenn., March 11, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-contro...
New Strong Sell Stocks for March 10th
BSET, CYRX, and DIN have been added to the Zacks Rank #5 (Strong Sell) List on March 10, 2022.
CryoPort, Inc. (CYRX) Reports Q4 Loss, Misses Revenue Estimates
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -780% and 2.48%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Cryoport Reports Fourth Quarter and Full Year 2021 Results
NASHVILLE, Tenn., Feb. 24, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...
Here's Why CryoPort, Inc. (CYRX) is Poised for a Turnaround After Losing 22.8% in 4 Weeks
CryoPort, Inc. (CYRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revis...
CryoPort, Inc. (CYRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cryoport Report's Fourth Quarter and 2021 Financial Results on February 24, 2022
NASHVILLE, Tenn., Feb. 15, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...
Cryoport Provides Positive Update on MVE Biological Solution's New Prague Facility
NASHVILLE, Tenn., Feb. 9, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industr...
Cryoport Reports Fire Damage at MVE's New Prague Facility
NASHVILLE, Tenn., Jan. 31, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...
Cryoport and Cell Matters Enter into Strategic Partnership
NASHVILLE, Tenn., Jan. 27, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu...
Cryoport to Present at the J.P. Morgan 40th Annual Healthcare Conference
NASHVILLE, Tenn., Jan. 5, 2022 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indust...
Cryoport, Inc. Prices Upsized $350.0 Million Convertible Senior Notes Offering
NASHVILLE, Tenn., Nov. 9, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the pricing...
Cryoport, Inc. Prices Registered Direct Placement of Common Stock
NASHVILLE, Tenn., Nov. 9, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced the pricing...
Cryoport, Inc. Announces Proposed Convertible Senior Notes Offering
NASHVILLE, Tenn., Nov. 8, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced its intenti...
Cryoport, Inc. Announces Proposed Registered Direct Placement of Common Stock
NASHVILLE, Tenn., Nov. 8, 2021 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced its intenti...
CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates
CryoPort, Inc. (CYRX) delivered earnings and revenue surprises of -20.00% and 3.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: CryoPort Q3 Earnings
CryoPort (NASDAQ:CYRX) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM. Here's what investors need to know about the announcement.
Cryoport Reports Record Third Quarter and Nine Months Revenue for 2021
NASHVILLE, Tenn., Nov. 4, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industr...
CRYOPDP, a Cryoport Company, Receives 2021 Europe Bioprocessing Excellence Award from IMAPAC
NASHVILLE, Tenn., Oct. 29, 2021 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences indu...
CryoPort, Inc. (CYRX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
CryoPort, Inc. (CYRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.